Teddy, the primary objective is 'blood or not' but 'ischema or not' has always been a secondary feature.....which they have now considerably improved. It is very important to note we are still scanning patients at PA and John Hunter which will provide more training data to continuously improve and refine the algorithms.
Also, its only a small data set but did you guys miss the part about 9 cases not identified with NCCT and 3 cases with CTP ?
Teddy, the primary objective is 'blood or not' but 'ischema or...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.79 |
Change
-0.045(2.45%) |
Mkt cap ! $153.0M | |||
| Open | High | Low | Value | Volume |
| $1.85 | $1.85 | $1.72 | $127.4K | 72.23K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8620 | $1.74 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.82 | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| EMV (ASX) Chart |